FUNXIONAL THERAPEUTICS
Funxional Therapeutics Ltd. develops pharmaceutical products in the United Kingdom. Its product candidates include BN83470 for the treatment of respiratory indications, initially asthma; BN83250 for the prevention of surgical adhesion formation and for the treatment of stroke; and FX125L, an orally available small molecule that belongs to a therapeutic class named broad spectrum chemokine inhibitors. The company also offers early stage preclinical programs that focus on Alzheimer's disease, autoimmune disorders, and pain and diabetes. Funxional Therapeutics Ltd. as founded in 2005 and is based in Cambridge, the United Kingdom.
FUNXIONAL THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2005-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.funxionaltherapeutics.com
Total Employee:
1+
Status:
Closed
Contact:
44 1223 451095
Email Addresses:
[email protected]
Total Funding:
12.2 M USD
Technology used in webpage:
DNS.COM
Similar Organizations
Auxeris Therapeutics
Auxeris Therapeutics is a biopharmaceutical company focused on the treatment of bone diseases.
LipoLek
LipoLek develops pharmaceutical products based on the nanotechnology.
Monument Therapeutics
Monument Therapeutics develops products to treat serious diseases of the central nervous system.
THC Pharm
THC Pharm develops drugs & medicinal products for the treatment of multimorbidity, cancer and neurological diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Ventech
Ventech investment in Series B - Funxional Therapeutics
Index Ventures
Index Ventures investment in Series B - Funxional Therapeutics
Novo Ventures
Novo Ventures investment in Series B - Funxional Therapeutics
Novo Ventures
Novo Ventures investment in Series A - Funxional Therapeutics
Index Ventures
Index Ventures investment in Series A - Funxional Therapeutics
Official Site Inspections
http://www.funxionaltherapeutics.com
Unable to get host informations!!!
More informations about "Funxional Therapeutics"
Funxional Therapeutics Company Profile 2025: Valuation, Funding ...
Information on valuation, funding, cap tables, investors, and executives for Funxional Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Funxional Therapeutics Ltd. (FXT) - life-sciences-europe.com
Funxional Therapeutics Ltd (FXT) is a privately held, clinical stage pharmaceutical company based in Cambridge, UK. FXT's focus is on novel anti-inflammatory therapies that exploit a …See details»
Funxional Therapeutics - Products, Competitors, Financials, …
Funxional Therapeutics was founded in 2005 based on intellectual property developed by Dr David Grainger and his colleagues at Cambridge University, in collaboration with Ipsen, a …See details»
Funxional Therapeutics - Boehringer Ingelheim - Medicxi
Funxional Therapeutics Ltd (FXT) is a privately held, clinical stage pharmaceutical company, focussing on novel anti-inflammatory therapies that exploit a new pathway discovered by FXT.See details»
Funxional Therapeutics - Company Profile - Tracxn
Mar 6, 2025 Funxional Therapeutics - Developer of anti-inflammatory therapies for respiratory disorders. Raised a total funding of $27.3M over 5 rounds from 6 investors.See details»
Funxional Therapeutics - Funding, Financials, Valuation & Investors
Funxional Therapeutics develops pharmaceutical products focusing on the treatment of various diseases and disorders.See details»
FUNXIONAL THERAPEUTICS LIMITED overview - Find and update …
Dec 12, 2017 FUNXIONAL THERAPEUTICS LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, …See details»
Funxional Therapeutics - Golden
A drug dicovery and development company focused on anti-inflammatory therapies for respiratory disorderSee details»
Funxional Therapeutics | VentureRadar
Funxional Theraputics Ltd develops novel human pharmaceuticals, exploiting relatively high-throughput functional screening assays to find compounds with unexpected modes of action.See details»
Funxional Therapeutics - Tech Company Profile - gaebler.com
Funxional Therapeutics is a biopharmaceutical company, located in Cambridge. Venture capital investment came from Novo Ventures and Index Ventures.See details»
Funxional Therapeutics — English version — IVAO
Send request Link www.funxionaltherapeutics.com Название компании Funxional Therapeutics Stage of the project Second stage Total Raised $12,200,000 Site Map Home News and …See details»
Funxional Therapeutics - Contacts, Employees, Board Members, …
Funxional Therapeutics has 1 current employee profile, CEO Konstantinos Efthymiopoulos. Funxional Therapeutics has 3 board members and advisors, including Martin Edwards.See details»
Boehringer Ingelheim and Funxional Therapeutics announce …
Jul 23, 2012 Funxional Therapeutics was founded by David Grainger with initial investment from Index Ventures and Novo A/S in 2006. Ventech led the Series B financing. Index Ventures’ …See details»
Boehringer Ingelheim and Funxional Therapeutics announce …
Aug 22, 2012 Boehringer Ingelheim, one of the world’s leading pharmaceutical companies, and Funxional Therapeutics, a clinical-stage, asset-centric, private company, have announced an …See details»
Boehringer Ingelheim acquires Funxional Therapeutics’ FX125L …
Jul 23, 2012 INGELHEIM, Germany and CAMBRIDGE, U.K.—Althoughfinancial details of the transaction were not disclosed, Boehringer Ingelheim announcedJuly 23 that it and Funxional …See details»
Funxional Successfully Completes Initial Clinical Trial of ... - Medindia
Advertisement "We are extremely pleased with the outcome of this initial clinical studywith FX125L," said Konstantinos Efthymiopoulos, CEO of FunxionalTherapeutics.See details»
Therapeutics Research Firm | Function Therapeutics
Function Therapeutics, Inc. is a research firm developing novel approaches and molecules for the treatment of certain inflammation-driven disorders.See details»
FX-125L - Drug Targets, Indications, Patents - Synapse
FX-125L: a CXCRs antagonists Drug, Initially developed by Funxional Therapeutics Ltd., Now, its global highest R&D status is Phase 2, Mechanism: CXCRs antagonists(CXC chemokine …See details»
Function Therapeutics - Crunchbase Company Profile & Funding
Function Therapeutics are anti-inflammatory medications that alter Protease-Activated Receptor signaling (PARmodulins).See details»
Beam Therapeutics Announces Positive Initial Data for BEAM-302 …
Mar 10, 2025 Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.See details»